
    
      1. To evaluate the Safety and Efficacy of four different short-course regimens of
           Amphotericin B emulsion in treatment of Kala-azar (visceral leishmaniasis) subjects who
           are either treatment naive or treatment resistant to other antileishmanial drugs except
           amphotericin B containing preparations.

        2. To assess the safety and efficacy of single-bolus infusion of Amphotericin B emulsion in
           treatment of Kala-azar.

      Subjects will be administered the study drug in either of the following four dose levels in
      an ascending manner, starting with the first dosage regimen:

        -  7.5 mg/kg on day 1 and day3 (Regimen 1)

        -  10 mg/kg on day 1, followed by 5 mg/kg on day 3 (Regimen 2)

        -  12.5 mg/kg on day 1, followed by 2.5 mg/kg on day 3 (Regimen 3)

        -  Single-bolus infusion of 15 mg/kg over 2-4 hours on day 1 (Regimen 4)
    
  